
Apple Bets on Health and AI With New Watches
By ROSS ANDERSON
|This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.

Published:
Updated:
When French tenor Roberto Alagna replaced the ailing Rolando Villazón in Gounod’s “Roméo et Juliette,” the Associated Press declared Mr. Alagna a “triumph,” proving that a tenor in need is a tenor indeed. This month Mr. Alagna looks likely to reach similar heights in Puccini’s “Madama Butterfly,” which he sings at the Metropolitan Opera beginning October 8. This represents quite a change of destiny for the tenor, whose path has been as rocky as that of any opera hero.

By ROSS ANDERSON
|
By MARIO NAVES
|
By THE NEW YORK SUN
|
By ALEX ZDAN
|
By LUKE FUNK
|
By LUKE FUNK
|
By GEORGE WILLIS
|
By A.R. HOFFMAN
|When French tenor Roberto Alagna replaced the ailing Rolando Villazón in Gounod’s “Roméo et Juliette,” the Associated Press declared Mr. Alagna a “triumph,” proving that a tenor in need is a tenor indeed. This month Mr. Alagna looks likely to reach similar heights in Puccini’s “Madama Butterfly,” which he sings at the Metropolitan Opera beginning October 8. This represents quite a change of destiny for the tenor, whose path has been as rocky as that of any opera hero.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.
Cancel anytime